Literature DB >> 2502132

Decreased human IL-2 receptor expression due to a protozoan pathogen.

F Kierszenbaum, M B Sztein, L A Beltz.   

Abstract

A number of parasites suppress immune responses during - and in some cases after - their establishment in their hosts. Many instances of altered levels of immunocompetence have been documented, but the early events and mechanisms leading to such impairment have not been elucidated. Here, Felipe Kierszenbaum and colleagues discuss the ability of the pathogenic protozoan Trypanosoma cruzi to suppress the expression of interleukin 2 receptors by human lymphocytes. Absence or reduced levels of this receptor would prevent lymphocytes from receiving the very important growth factor signal that allows them to continue their division cycle and to proliferate after activation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2502132     DOI: 10.1016/0167-5699(89)90246-6

Source DB:  PubMed          Journal:  Immunol Today        ISSN: 0167-5699


  10 in total

1.  In vitro simulation of immunosuppression caused by Trypanosoma brucei.

Authors:  M Sileghem; A Darji; P De Baetselier
Journal:  Immunology       Date:  1991-06       Impact factor: 7.397

2.  Trypanosoma cruzi-induced suppression of human peripheral blood lymphocytes activated via the alternative (CD2) pathway.

Authors:  L A Beltz; F Kierszenbaum; M B Sztein
Journal:  Infect Immun       Date:  1990-04       Impact factor: 3.441

3.  Desialylation of T lymphocytes overcomes the monocyte dependency of pokeweed mitogen-induced T-cell activation.

Authors:  T Gallart; M Angel de la Fuente; J Josep Barceló; J Alberola-Ila; F Lozano
Journal:  Immunology       Date:  1997-01       Impact factor: 7.397

4.  Arginase in parasitic infections: macrophage activation, immunosuppression, and intracellular signals.

Authors:  Cinthia C Stempin; Laura R Dulgerian; Vanina V Garrido; Fabio M Cerban
Journal:  J Biomed Biotechnol       Date:  2009-12-09

5.  T-cell abnormality and defective interleukin-2 production in patients with carcinoma of the urinary bladder with schistosomiasis.

Authors:  S Raziuddin; S Shetty; A Ibrahim
Journal:  J Clin Immunol       Date:  1991-03       Impact factor: 8.317

6.  Suppression by Trypanosoma brucei rhodesiense of the capacities of human T lymphocytes to express interleukin-2 receptors and proliferate after mitogenic stimulation.

Authors:  F Kierszenbaum; S Muthukkumar; L A Beltz; M B Sztein
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

7.  In vitro responses of cheetah mononuclear cells to feline herpesvirus-1 and Cryptococcus neoformans.

Authors:  M A Miller-Edge; M B Worley
Journal:  Vet Immunol Immunopathol       Date:  1992-01-15       Impact factor: 2.046

8.  Immunohistochemical characterization of infiltrating cells in human chronic chagasic myocarditis: comparison with myocardial rejection process.

Authors:  M de L Higuchi; P S Gutierrez; V D Aiello; S Palomino; E Bocchi; J Kalil; G Bellotti; F Pileggi
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

9.  A soluble factor from Trypanosoma cruzi inhibits transforming growth factor-ß-induced MAP kinase activation and gene expression in dermal fibroblasts.

Authors:  G Adam Mott; Jaime A Costales; Barbara A Burleigh
Journal:  PLoS One       Date:  2011-09-08       Impact factor: 3.240

10.  A Trypanosoma cruzi membrane protein shares an epitope with a lymphocyte activation antigen and induces crossreactive antibodies.

Authors:  C Hernández-Munaín; J L De Diego; A Alcina; M Fresno
Journal:  J Exp Med       Date:  1992-06-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.